Jnj competitors.

Value. Procter & Gamble beats JNJ on price-to-sales. These companies trade at a P/S of 4.2 and 3.24, respectively. PG is also ahead when it comes to price-to-book, as it has a P/B of 3.69. On the ...

Jnj competitors. Things To Know About Jnj competitors.

In today’s digital age, having a reliable internet and cable provider is crucial for staying connected and entertained. For residents of Angleton, Texas, one of the options available is Suddenlink. However, it’s always a good idea to compar...The Top 7 Johnson & Johnson Competitors: Pfizer, Merck, GlaxoSmithKline, Bayer, Abbott, Bristol Myers Squibb, Medtronic. Together, including the revenue of J&J, they contribute nearly $342 billion in annual revenues to the medical sector. Their total employee count is close to 730,000. According to the issued ratings of 14 analysts in the last year, the consensus rating for Johnson & Johnson stock is Hold based on the current 8 hold ratings and 6 buy ratings for JNJ. The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00.View the latest top stories from CNN Money Visit CNNMoney.com for daily and breaking news from the world of business.

In today’s fast-paced world, online grocery shopping has become increasingly popular. With the convenience it offers, more and more people are turning to online platforms to fulfill their grocery needs. When it comes to online grocery shopp...• Complete competitor analysis each quarter summarizing peer results by providing insightful commentary on guidance, consensus, and stock market trends to JNJ CEO and CFO as well as Investor ...

Among Ikea’s main competitors in the United States are the furniture stores Ashley Furniture and American Furniture Warehouse. Another large competitor is Walmart, which does not exclusively sell home furnishings.

Johnson And Johnson's current and past Price to Sales Ratio (PS) Ratios over the last year - CSIMarketMay 17, 2023 · We believe Bristol Myers Squibb stock (NYSE: BMY) is a better pick than its industry peer, Johnson & Johnson (NYSE: JNJ). J&J trades at a higher valuation of 4.4x trailing revenues, compared to 3 ... Johnson & Johnson's top competitors include Pfizer, Novartis and Merck. Unlock 18 more competitors → Select to follow all companies RANK COMPANY CEO CEO RATING EMPLOYEES FUNDING REVENUE Joaquin Duato Chairman & CEO 77/100 152,700 $0 $120.1B 1 Albert Bourla Chairman & CEO 76/100 83,000 - - $77.9B 2 Vasant Narasimhan CEO 84/100 103,000 - - $51B 3Johnson & Johnson does not undertake to update any forward-looking statement as a result of new information or future events or developments. 2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0%* and adjusted operational growth of 7.6%* 2023 First-Quarter basic loss per share of ($0.03) decreasing ...Owning Kenvue ( NYSE: KVUE ), the consumer health spin-off of Johnson & Johnson ( JNJ ), absolutely is not a poor decision. Kenvue has a diversified portfolio of brands, 10 of which generated 2022 ...

When it comes to baseball bats, one brand that stands out is Slugger. Known for their high-quality craftsmanship and exceptional performance, Slugger bats have dominated the market for years.

J&J Says They Made a Deal with ARC in 1895 (Score: 5, Informative) Johnson & Johnson on Wednesday sued the American Red Cross over the use by the relief group and its partners of J&J's trademark red cross logo on first aid kits, hand sanitizer and medical gloves sold to the public.

JNJ Competitors | Johnson & Johnson Common Stock Stock - Yahoo! Finance. N.p., n.d. Web. 08 Dec. 2013. . Read More. Proctor And Gamble Scope Case Analysis 1672 Words | 4 Pages. Each division has its own brand management, sales, finance, product development and operations line management and was evaluated as a …May 26, 2011 · A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson’s Annual Report on Form 10-K for the fiscal year ended January 2, 2011. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. The Top Johnson & Johnson competitors are Pfizer, Novartis, Glaxo Smith Kline, Bayer, Merck, Abbott, Roche and others. Johnson & Johnson is American multinational pharmaceutical and medical equipment, and consumer goods manufacturing company. It was established in the year 1886 and headquartered in New Jersey.The following chart compares the dividend increases for PG and JNJ: The Procter & Gamble dividend increase was double that of Johnson & Johnson. It is not that JNJ's dividend increase was bad. In ...We believe Bristol Myers Squibb stock (NYSE: BMY) is a better pick than its industry peer, Johnson & Johnson (NYSE: JNJ). J&J trades at a higher valuation of 4.4x trailing revenues, compared to 3 ...Johnson And Johnson's current Dividend, dividend pay out and yield comparisons to industry, sector, and S&P 500

Dec 1, 2023 · Johnson & Johnson pays an annual dividend of $4.76 per share and has a dividend yield of 3.0%. Eli Lilly and Company pays an annual dividend of $4.52 per share and has a dividend yield of 0.8%. Johnson & Johnson pays out 35.3% of its earnings in the form of a dividend. JNJ reported $82.58 billion in revenue for the 2020 fiscal year—$43.13 billion from the United States while the remaining $39.45 billion came from international sources. Johnson & Johnson ...Johnson & Johnson Company is a Pharmaceutical company all over the world. It was found in 1886 by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson. The company produced its first products in 1886 and incorporated in 1887. It became a public company in 1944, listed shares on the New York Stock Exchange with …According to the issued ratings of 14 analysts in the last year, the consensus rating for Johnson & Johnson stock is Hold based on the current 8 hold ratings and 6 buy ratings for JNJ. The average twelve-month price prediction for Johnson & Johnson is $169.19 with a high price target of $215.00 and a low price target of $52.00.Sep 25, 2013 ... Most investors recognize Johnson & Johnson (JNJ 2.40%) as a consumer ... competitors -- Boston Scientific (BSX 0.45%), Medtronic (MDT 0.91 ...

Click to enlarge (Source - SEC) Kenvue’s Market & Competition. According to a 2022 market research report by Research and Markets, the global market for consumer healthcare products was an ...

Jun 23, 2020 ... Johnson & Johnson exits fairness cream market, but what about competitors? ... Though Johnson & Johnson (J&J), the US healthcare and FMCG giant ...F. Hoffmann-La Roche Ltd: Overview. F. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases.Some of JNJ competitors such as Pfizer, Abbots, and Merck Co. whose resources are also significantly greater in the healthcare industry, put pressure on Johnson & Johnson through lower pricing, dropping cost, constantly design new products, or update existing products and services to meet customer's demand and bring new customers to the fold.In today’s fast-paced world, online shopping has become the go-to choice for many consumers. With the convenience of browsing and purchasing products from the comfort of their homes, shoppers are increasingly turning to online retailers.Find useful insights on Johnson & Johnson’s company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Johnson & Johnson.Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the ...Dec 1, 2023 · Johnson & Johnson pays an annual dividend of $4.76 per share and has a dividend yield of 3.0%. Eli Lilly and Company pays an annual dividend of $4.52 per share and has a dividend yield of 0.8%. Johnson & Johnson pays out 35.3% of its earnings in the form of a dividend.

Dec 1, 2023 · This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment ...

Merck main competitors are AbbVie, Bristol-Myers Squibb, and Eli Lilly and Company. Competitor Summary. See how Merck compares to its main competitors: Johnson & Johnson has the most employees (134,500). Employees at AbbVie earn more than most of the competitors, with an average yearly salary of $107,969. The oldest company is Pfizer, founded ...

Due to inventory build up in the second quarter 2023, Johnson And Johnson's inventory turnover ratio sequentially decreased to 2.58 in the second quarter 2023, unsurprisingly, as the Johnson And Johnson markets continue to deteriorate, and JNJ's faces growing challenges to bring down its inventories. Johnson And Johnson's average inventory …Price Ratios. Other Ratios. Other Metrics. Income Statement. Balance Sheet. Cash Flow Statement. Key Financial Ratios. View Annual Reports. Ten years of annual and quarterly financial ratios and margins for analysis of Johnson & Johnson (JNJ).Analysis of Johnson & Johnson 2021. Johnson & Johnson is a famous multinational corporation that manufactures and markets pharmaceuticals, medical devices, and consumer packaged goods. The company's core focus is to develop products related to human health and well-being. In this effort, the company, through its subsidiaries, operates over 120 ...Enter The Parametars. Mountain Comparison Candle OHLC OHLC Weekly OHLC Monthly Line. Moving Average Envelopes Moving Average EMA Moving Average Price Channels Bollinger Bands Keltner Channels (KC) Period (days): JNJ $158.3800 $3.7200 2.41%. Volume (M): 10,343 Open : 156.44 52 Wk Avg : 161.91.Economic indicators with impact on Johnson And Johnson's sales, demand side and costs, supply side - CSIMarketAnd this unwavering commitment hasn’t gone unnoticed: Fortune just ranked Johnson & Johnson as a Top 50 All-Star on its World’s Most Admired Companies list for the 20th consecutive year. For 2022, the company ranked #1 on the Pharmaceutical Industry list for the ninth year in a row and in the top 20 on the overall Top 50 All-Stars list.JNJ Company Profile >> Back to JNJ Fundamentals at a Glance >> Back to JNJ Growth Comparisons Annual Net Income Growth Comment Johnson And Johnson experienced detoriation of Annual Net Income for the fiscal year ended 2022 by -14.07% to $ 17,941.00 millions, compare to $ 20,878.00 in Annual Net Income reported in the previous year.Effective Tax Rate Comment: On the trailing twelve months basis Company's effective tax rate in III. Quarter decreased compare to previous quarter to 16.43 %, below company's average Effective Tax Rate. Within Major Pharmaceutical Preparations industry 2 other companies have achieved higher Effective Tax Rate. While total ranking remained …

Considering the Leverage Ratio throughout the previous twelve months, and due to repayements of liabilities of -21.65% during ttm concluding in III Quarter 2023, Johnson And Johnson trailing twelve months Leverage Ratio decreased 1.29 above the Johnson And Johnson's averageLeverage Ratio To set this into perspective, it is worth nothing, …Sep 25, 2013 ... Most investors recognize Johnson & Johnson (JNJ 2.40%) as a consumer ... competitors -- Boston Scientific (BSX 0.45%), Medtronic (MDT 0.91 ...Feb 2, 2022 · And this unwavering commitment hasn’t gone unnoticed: Fortune just ranked Johnson & Johnson as a Top 50 All-Star on its World’s Most Admired Companies list for the 20th consecutive year. For 2022, the company ranked #1 on the Pharmaceutical Industry list for the ninth year in a row and in the top 20 on the overall Top 50 All-Stars list. Instagram:https://instagram. beam stock forecastpara stock newspractice options trading appzyne Sep 28, 2022 · NEW BRUNSWICK, N.J. September 28, 2022 — Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand comes to life through a compelling purpose, and a ... Competitors. Sanofi-Aventis , ... Johnson & Johnson should be over the setbacks caused by its former CEO and the string of recalls it was made to handle. Now is the real test. Investors should ... sotkbcred blackstone Walmart is going head-to-head with Amazon with its new Walmart+ membership program set to launch later this month. In a challenge with Amazon, Walmart is expected to unveil its own membership shopping service later this month. Dubbed Walmar... best overseas forex brokers us residents JNJ EPS Net third quarter 2023 Y/Y Growth Comment: Johnson and Johnson achieved in the third quarter 2023, above Company average EPS Net surge of 507.74% year on year, to $ 10.21 . Looking into third quarter 2023 results within Major Pharmaceutical Preparations industry 2 other companies have achieved higher EPS Net growth. While Johnson And …When it comes to purchasing a new SUV, safety is a top priority for many buyers. The 2022 Outlander SUV offers a range of advanced safety features that set it apart from its competitors.In today’s fast-paced world, home security has become a top priority for homeowners. With advancements in technology, there are now a plethora of options available when it comes to choosing the right home security system. One popular choice...